HKD 0.4
(-2.44%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -13.69 Million | 9.61 Million | 3.31 Million | -8.77 Million | -1.45 Million | -270 Thousand |
Net Income | -21.4 Million | -6.66 Million | -1.32 Million | -14.12 Million | -4.44 Million | -923 Thousand |
Depreciation & Amortization | 2.08 Million | 5.47 Million | 5.36 Million | 6.02 Million | 2.98 Million | 3.6 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -4.96 Million | 10.29 Million | 3.91 Million | -3.32 Million | 668 Thousand | 112 Thousand |
Other non-cash items | 10.58 Million | 507 Thousand | -4.63 Million | 2.65 Million | -659 Thousand | -3.06 Million |
Investing Cash Flow | -1.02 Million | -1.21 Million | -2.45 Million | -3.45 Million | 922 Thousand | -3.7 Million |
Investments in PPE | -1.38 Million | -1.28 Million | -3.22 Million | -1.75 Million | -525 Thousand | -3.8 Million |
Acquisitions | - | - | - | -2.04 Million | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 364 Thousand | 66 Thousand | 767 Thousand | 337 Thousand | 1.44 Million | 95 Thousand |
Financing Cash Flow | -255 Thousand | -2.88 Million | -2.76 Million | 2.82 Million | 3000.00 | - |
Debt repayment | -255 Thousand | -2.88 Million | -2.76 Million | -2.8 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 5.14 Million | - | - |
Other Financing Activities | -255 Thousand | -2.88 Million | -2.76 Million | 490 Thousand | 3000.00 | - |
Accounts receivables | -2.17 Million | 3.98 Million | -200 Thousand | -4.46 Million | 3.39 Million | 5.53 Million |
Accounts payables | 2.17 Million | -3.98 Million | 200 Thousand | 4.46 Million | -3.39 Million | - |
Inventory | 1.73 Million | -489 Thousand | -204 Thousand | -431 Thousand | 1.18 Million | 20 Thousand |
Other working capital | -6.69 Million | 10.78 Million | 4.11 Million | -2.89 Million | -515 Thousand | 92 Thousand |
Cash at beginning of period | 34.81 Million | 29.3 Million | 31.36 Million | 41.41 Million | 41.72 Million | 44.63 Million |
Cash at end of period | 19.72 Million | 34.81 Million | 29.3 Million | 31.36 Million | 41.41 Million | 41.72 Million |
Capital Expenditure | -1.38 Million | -1.28 Million | -3.22 Million | -1.75 Million | -525 Thousand | -3.8 Million |
Effect of forex changes on cash | -111 Thousand | -10 Thousand | -148 Thousand | -651 Thousand | 224 Thousand | 1.06 Million |
Net cash flow / Change in cash | -15.08 Million | 5.5 Million | -2.05 Million | -10.05 Million | -304 Thousand | -2.91 Million |
Free Cash Flow | -15.08 Million | 8.32 Million | 91 Thousand | -10.52 Million | -1.97 Million | -4.07 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -3.24 Million | -3.24 Million | -21.4 Million | -16.97 Million | -3.37 Million | 471 Thousand |
Depreciation & Amortization | 89.5 Thousand | 89.5 Thousand | 2.08 Million | - | - | 1.05 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -4.96 Million | - | - | - |
Other non-cash items | -5.05 Million | -5.05 Million | 10.58 Million | 16.97 Million | 3.37 Million | -471 Thousand |
Investing Cash Flow | -342 Thousand | -342 Thousand | -1.02 Million | - | - | -44.1 Thousand |
Investments in PPE | -442 Thousand | -442 Thousand | -1.38 Million | - | - | -220.53 Thousand |
Acquisitions | - | - | - | - | - | 176.42 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 100 Thousand | 100 Thousand | 364 Thousand | - | - | - |
Financing Cash Flow | 6.69 Million | 6.69 Million | -255 Thousand | - | - | - |
Debt repayment | - | - | -255 Thousand | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 6.69 Million | 6.69 Million | - | - | - | - |
Accounts receivables | - | - | -2.17 Million | - | - | - |
Accounts payables | - | - | 2.17 Million | - | - | - |
Inventory | - | - | 1.73 Million | - | - | - |
Other working capital | - | - | -6.69 Million | - | - | - |
Cash at beginning of period | - | - | 34.81 Million | - | - | 39.08 Million |
Cash at end of period | -1.94 Million | -1.94 Million | 19.72 Million | - | - | 29.12 Million |
Capital Expenditure | -442 Thousand | -442 Thousand | -1.38 Million | - | - | -220.53 Thousand |
Effect of forex changes on cash | -87 Thousand | -87 Thousand | -111 Thousand | - | - | - |
Net cash flow / Change in cash | -1.94 Million | -1.94 Million | -15.08 Million | - | - | -9.96 Million |
Free Cash Flow | -8.65 Million | -8.65 Million | -15.08 Million | - | - | -9.11 Million |
CLEDUCATE
BODI
TARINI
REFEXRENEW
600128
DTRL